128 related articles for article (PubMed ID: 28667300)
1. Association of plasma C-reactive protein level with the prevalence of colorectal adenoma: the Colorectal Adenoma Study in Tokyo.
Kigawa N; Budhathoki S; Yamaji T; Iwasaki M; Inoue M; Tsugane S
Sci Rep; 2017 Jun; 7(1):4456. PubMed ID: 28667300
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and colorectal adenomas: Self Defense Forces Health Study.
Otake T; Uezono K; Takahashi R; Fukumoto J; Tabata S; Abe H; Tajima O; Mizoue T; Ohnaka K; Kono S
Cancer Sci; 2009 Apr; 100(4):709-14. PubMed ID: 19469014
[TBL] [Abstract][Full Text] [Related]
3. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.
Wei EK; Giovannucci E; Selhub J; Fuchs CS; Hankinson SE; Ma J
J Natl Cancer Inst; 2005 May; 97(9):684-92. PubMed ID: 15870439
[TBL] [Abstract][Full Text] [Related]
4. Visceral fat volume and the prevalence of colorectal adenoma.
Yamaji T; Iwasaki M; Sasazuki S; Kurahashi N; Mutoh M; Yamamoto S; Suzuki M; Moriyama N; Wakabayashi K; Tsugane S
Am J Epidemiol; 2009 Dec; 170(12):1502-11. PubMed ID: 19923108
[TBL] [Abstract][Full Text] [Related]
5. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia.
Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
Int J Obes (Lond); 2012 Mar; 36(3):440-7. PubMed ID: 21673650
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pro-inflammatory markers plasma C-reactive protein and urinary prostaglandin-E2 metabolite in colorectal adenoma risk.
Davenport JR; Cai Q; Ness RM; Milne G; Zhao Z; Smalley WE; Zheng W; Shrubsole MJ
Mol Carcinog; 2016 Aug; 55(8):1251-61. PubMed ID: 26333108
[TBL] [Abstract][Full Text] [Related]
7. Dietary heterocyclic amine intake, NAT2 genetic polymorphism, and colorectal adenoma risk: the colorectal adenoma study in Tokyo.
Budhathoki S; Iwasaki M; Yamaji T; Sasazuki S; Takachi R; Sakamoto H; Yoshida T; Tsugane S
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):613-20. PubMed ID: 25604583
[TBL] [Abstract][Full Text] [Related]
8. Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies.
Godos J; Biondi A; Galvano F; Basile F; Sciacca S; Giovannucci EL; Grosso G
World J Gastroenterol; 2017 Mar; 23(10):1909-1919. PubMed ID: 28348498
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein and colorectal adenoma in the CLUE II cohort.
Tsilidis KK; Erlinger TP; Rifai N; Hoffman S; Hoffman-Bolton J; Helzlsouer KJ; Platz EA
Cancer Causes Control; 2008 Aug; 19(6):559-67. PubMed ID: 18214695
[TBL] [Abstract][Full Text] [Related]
10. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men.
Chiu HM; Lin JT; Chen TH; Lee YC; Chiu YH; Liang JT; Shun CT; Wu MS
Am J Gastroenterol; 2008 Sep; 103(9):2317-25. PubMed ID: 18844617
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein and the risk of incident colorectal cancer.
Erlinger TP; Platz EA; Rifai N; Helzlsouer KJ
JAMA; 2004 Feb; 291(5):585-90. PubMed ID: 14762037
[TBL] [Abstract][Full Text] [Related]
12. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
[TBL] [Abstract][Full Text] [Related]
13. [C-reactive protein level and colorectal adenoma].
Park SK; Park DI; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim JE; Son HJ
Korean J Gastroenterol; 2008 Apr; 51(4):225-31. PubMed ID: 18516001
[TBL] [Abstract][Full Text] [Related]
14. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women.
Song M; Mehta RS; Wu K; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
Cancer Prev Res (Phila); 2016 Jan; 9(1):27-34. PubMed ID: 26511487
[TBL] [Abstract][Full Text] [Related]
15. The association between predicted inflammatory status and colorectal adenoma.
Kim S; Song S; Kim YS; Yang SY; Lee JE
Sci Rep; 2020 Feb; 10(1):2433. PubMed ID: 32051482
[TBL] [Abstract][Full Text] [Related]
16. Selenium and colorectal adenoma: results of a pooled analysis.
Jacobs ET; Jiang R; Alberts DS; Greenberg ER; Gunter EW; Karagas MR; Lanza E; Ratnasinghe L; Reid ME; Schatzkin A; Smith-Warner SA; Wallace K; MartÃnez ME
J Natl Cancer Inst; 2004 Nov; 96(22):1669-75. PubMed ID: 15547179
[TBL] [Abstract][Full Text] [Related]
17. Serum triglycerides and colorectal adenoma in a case-control study among cancer screening examinees (Japan).
Otani T; Iwasaki M; Ikeda S; Kozu T; Saito H; Mutoh M; Wakabayashi K; Tsugane S
Cancer Causes Control; 2006 Dec; 17(10):1245-52. PubMed ID: 17111255
[TBL] [Abstract][Full Text] [Related]
18. Plasma enterolignans are associated with lower colorectal adenoma risk.
Kuijsten A; Arts IC; Hollman PC; van't Veer P; Kampman E
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1132-6. PubMed ID: 16775171
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of inflammatory cytokines and risk of colorectal adenomas.
Kim S; Keku TO; Martin C; Galanko J; Woosley JT; Schroeder JC; Satia JA; Halabi S; Sandler RS
Cancer Res; 2008 Jan; 68(1):323-8. PubMed ID: 18172326
[TBL] [Abstract][Full Text] [Related]
20. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study.
Kang HW; Kim D; Kim HJ; Kim CH; Kim YS; Park MJ; Kim JS; Cho SH; Sung MW; Jung HC; Lee HS; Song IS
Am J Gastroenterol; 2010 Jan; 105(1):178-87. PubMed ID: 19755965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
